Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaliman

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Acta Medica Austriaca|January 1, 1978
[Diagnosis of extracranial carotid stenoses using the Doppler sonography]J Kaliman, M Deutsch, E Valencak
American Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1989
Platelet aggregation and platelet sensitivity-behaviour during normal and abnormal glucose tolerance testingI Virgolini, J Kaliman, H Sinzinger
Wiener Klinische Wochenschrift|September 16, 1983
[Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin]J Kaliman, M Cromwell, H Sinzinger
Lymphology|April 19, 2000
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersH Sinzinger, J Kaliman, A Oguogho
Artery|January 1, 1980
Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart diseaseJ Kaliman, K Widhalm, W Strobl
Lancet (London, England)|March 10, 1979
H.D.L. cholesterol in peripheral vascular diseaseH Zilcher, J Kaliman, M Müller
Lymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H Sinzinger
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
Prostaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J Kaliman
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Acta Medica Austriaca|January 1, 1978
[Diagnosis of extracranial carotid stenoses using the Doppler sonography]J Kaliman, M Deutsch, E Valencak
American Journal of Hematology|May 1, 1985
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular diseaseP Fitscha, J Kaliman, H Sinzinger
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1989
Platelet aggregation and platelet sensitivity-behaviour during normal and abnormal glucose tolerance testingI Virgolini, J Kaliman, H Sinzinger
Wiener Klinische Wochenschrift|September 16, 1983
[Venous prostacycline synthesis and plasma thromboxane B2 after low-dose aspirin]J Kaliman, M Cromwell, H Sinzinger
Lymphology|April 19, 2000
Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared with non-smokersH Sinzinger, J Kaliman, A Oguogho
Artery|January 1, 1980
Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart diseaseJ Kaliman, K Widhalm, W Strobl
Lancet (London, England)|March 10, 1979
H.D.L. cholesterol in peripheral vascular diseaseH Zilcher, J Kaliman, M Müller
Lymphology|February 9, 1999
Levels of eicosanoids (6-oxo-PGF1 alpha and 8-epi-PGF2 alpha) in human and porcine lymphatics and lymphA Oguogho, J Kaliman, H Sinzinger
Lymphology|October 6, 1997
Isoprostane 8-epi-prostaglandin F2 alpha is a potent contractor of human peripheral lymphaticsH Sinzinger, A Oguogho, J Kaliman
Prostaglandins|June 1, 1987
Prostaglandin I2 during radiolabelling improves recovery, but does not change platelet half-life and platelet uptake over active human lesion sitesH Sinzinger, P Fitscha, J Kaliman
Pageof 10